DOI:
10.1055/s-00000077
Seminars in Thrombosis and Hemostasis
LinksClose Window
References
Möricke A, Reiter A, Zimmermann M. et al; German-Austrian-Swiss ALL-BFM Study Group.
Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95.
Blood 2008;
111 (09) 4477-4489
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.